Dongju Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Interleukin-33 drives abnormal bone remodeling in ankylosing spondylitis via inhibition of osteoclast differentiation.

Interleukin-33 drives abnormal bone remodeling in ankylosing spondylitis via inhibition of osteoclast differentiation.

Journal: Joint bone spine
Published: March 30, 2026

Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis.

Co-administration of calcium carbonate or sodium bicarbonate prevents esomeprazole-induced osteoporosis.

Journal: Scientific reports
Published: February 10, 2026

Osteoclast-derived DEL1 promotes pathological bone formation in ankylosing spondylitis by regulating RUNX2 expression in osteoblasts.

Osteoclast-derived DEL1 promotes pathological bone formation in ankylosing spondylitis by regulating RUNX2 expression in osteoblasts.

Journal: Differentiation; research in biological diversity
Published: January 20, 2026

Transforming growth factor-β1 promotes initiation of entheseal pathological bone formation via osteonectin induction in ankylosing spondylitis.

Transforming growth factor-β1 promotes initiation of entheseal pathological bone formation via osteonectin induction in ankylosing spondylitis.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: July 09, 2025

Tracking clonal dynamics of CD8 T cells and immune dysregulation in progression of systemic lupus erythematosus with nephritis.

Tracking clonal dynamics of CD8 T cells and immune dysregulation in progression of systemic lupus erythematosus with nephritis.

Journal: Experimental & molecular medicine
Published: January 14, 2025

Wnt5a exacerbates pathological bone features and trabecular bone loss in curdlan-injected SKG mice via osteoclast activation.

Wnt5a exacerbates pathological bone features and trabecular bone loss in curdlan-injected SKG mice via osteoclast activation.

Journal: BMB reports
Published: October 09, 2024

Targeting osteoclast-derived DPP4 alleviates inflammation-mediated ectopic bone formation in ankylosing spondylitis.

Targeting osteoclast-derived DPP4 alleviates inflammation-mediated ectopic bone formation in ankylosing spondylitis.

Journal: Arthritis research & therapy
Published: September 29, 2024

Effects of phospholipase D1-inhibitory peptide on the growth and metastasis of gastric cancer cells.

Effects of phospholipase D1-inhibitory peptide on the growth and metastasis of gastric cancer cells.

Journal: Molecules and cells
Published: July 26, 2024

Complement factor H-related protein 5 alleviates joint inflammation and osteoclast differentiation by disrupting RANK-JNK signaling in collagen antibody-induced arthritis mouse model.

Complement factor H-related protein 5 alleviates joint inflammation and osteoclast differentiation by disrupting RANK-JNK signaling in collagen antibody-induced arthritis mouse model.

Journal: Cytokine
Published: July 15, 2024
Showing 1-9 of 9

Last Updated: 09/26/2026